Active	Status	Sponsor type	Region	Phase	Filter
3 Active 6 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Karakas, Mahir
FAIR-HF2, NCT03036462 / 2016-000068-40: Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality	Completed	4	1120	Europe, RoW	Iron, Saline, salin	Universitätsklinikum Hamburg-Eppendorf, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), Charite University, Berlin, Germany	Systolic Heart Failure, Iron Deficiency	05/24	05/24
iCHF-2, NCT03991000: Iron in Patients With Cardiovascular Disease	Terminated	3	8	Europe	Ferric carboxymaltose, Saline	Dr. med. Mahir Karakas	Cardiovascular Diseases, Anemia, Iron-deficiency, Acute Myocardial Infarction, Atrial Fibrillation, Systolic Heart Failure	12/21	12/21
AGNES-19, NCT05156671: Adrecizumab (HAM8101) to Improve Prognosis and Outcomes in COVID-19 Trial	Terminated	2	16	Europe	Adrecizumab (HAM 8101), Placebo, Saline	Universitätsklinikum Hamburg-Eppendorf	COVID-19	08/23	11/23